Table 2 Baseline characteristics of analysis group
Variables | Analysis group | HCC patients with PVTT | Controls | P value |
|---|---|---|---|---|
Sex F/M | 9/64 | 4/17 | 5/47 | 0.27 |
Age (years) | 57.88 ± 10.03 | 55.33 ± 9.62 | 58.90 ± 10.10 | 0.17 |
ALT | 27 (10–261.1) | 39 (10–147) | 24.5 (10–261.1) | 0.97 |
AST | 38 (13–291) | 47 (13–105) | 36.5 (17–291) | 0.38 |
TBiL | 17.8 (8.5–457) | 22.4 (9.4–407.9) | 17.35 (8.5–457.0) | 0.26 |
ALB | 36.98 ± 4.78 | 35.96 ± 4.27 | 37.39 ± 4.96 | 0.25 |
D-Dimer (mg/L) | 1.1 (0.27–15.61) | 2.12 (0.27–15.61) | 0.56 (0.10–13.95) | 0.001 |
PTA | 82.31 ± 12.92 | 79.84 ± 11.34 | 83.31 ± 13.48 | 0.30 |
PLT (×109/L) | 161.96 ± 102.87 | 173.57 ± 118.47 | 157.27 ± 96.73 | 0.54 |
AFP | 393.09 (1.33–1210.0) | 469.17(3.10–1210) | 362.36 (1.7–1210) | 0.21 |
PIVKA-II (mAU/ml) | 196.12 (12–75,000.00) | 995.8 (12–75,000.00) | 94.87 (13–70,997.0) | 0.003 |
Child-Pugh class | ||||
A | 37 | 9 | 28 | 0.45 |
B | 36 | 12 | 24 | |
HBsAg (COI) | 4512 (12.2–7542.0) | 5067.0 (62.33–7070.0) | 4106 (12.2–7542.0) | 0.35 |
HBeAg | ||||
Positive | 32 | 11 | 21 | 0.43 |
Negative | 41 | 10 | 31 | |
HBV-DNA | 5800.0 (0.0–4.16x107) | 4800.0 (0.0–2.99x106) | 6285.0 (0.0–4.16x107) | 0.81 |